Why HCW Biologics Stock Is Surging On Thursday?

Benzinga02:58

The clinical-stage biopharmaceutical firm announced the pricing of a private placement offering to raise approximately $4 million. The company is issuing an aggregate of 2,846,975 units to a group of ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2637352681?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/21/Growing-Stock-Market-Chart-With-Candlest_2.jpeg","is_english":true,"pubTime":"2026-05-22 02:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2637352681","market":"hk","top_or_hot":-1,"title":"Why HCW Biologics Stock Is Surging On Thursday?","media":"Benzinga","content":"<div>\n<p>The clinical-stage biopharmaceutical firm announced the pricing of a private placement offering to raise approximately $4 million. The company is issuing an aggregate of 2,846,975 units to a group of ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why HCW Biologics Stock Is Surging On Thursday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy HCW Biologics Stock Is Surging On Thursday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-22 02:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The clinical-stage biopharmaceutical firm announced the pricing of a private placement offering to raise approximately $4 million. The company is issuing an aggregate of 2,846,975 units to a group of ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday","article_id":"2637352681","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/05/21/Growing-Stock-Market-Chart-With-Candlest_2.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/05/52729890/why-hcw-biologics-stock-is-surging-on-thursday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2637352681","pubTimestamp":1779389880,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"HCW Biologics Inc. (NASDAQ:HCWB) stock is rallying after securing a $4 million private placement to fund its clinical pipeline. Read the full market breakdown.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4217":"自存仓储房地产信托","SMA":"Smartstop Self Storage REIT Inc","BK4539":"次新股","HCWB":"HCW Biologics Inc."},"translate_title":"为什么HCW Biologics股价周四飙升？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMA":0.9,"HCWB":1.5},"content_text":"The clinical-stage biopharmaceutical firm announced the pricing of a private placement offering to raise approximately $4 million. The company is issuing an aggregate of 2,846,975 units to a group of healthcare investors at a purchase price of $1.405 per unit.\nManagement intends to deploy the net proceeds to advance its clinical pipeline. Specifically, the capital will fund clinical trials for HCW9302 and progress IND-enabling studies for its T-Cell Engager, HCW11-018b, and its second-generation immune checkpoint inhibitor, HCW11-040. The funds will also support general corporate purposes and settle outstanding debts.\nThe capital raise provides critical liquidity; the company held cash and equivalents of $1.23 million, down from $1.95 million a year ago. \nThe announcement halted a two-day slide where retail investors locked in profits following a massive 262% surge driven by strong first quarter financial results and an exclusive worldwide licensing agreement with Trimmune.\nHCWB is in a stretched momentum phase: RSI is 84.05, signaling the move is overbought and vulnerable to pullbacks, even if the trend remains up. \nPrice is also extremely extended versus its short-term trend gauges, trading about 350% above the 20-day SMA (61 cents) and about 424% above the 50-day SMA (52 cents). It's still only about 28% above the 200-day SMA ($2.13), making that longer-term average a key \"line in the sand\" if the stock starts to mean-revert.\nThe moving-average structure is mixed: the 20-day SMA is above the 50-day SMA (bullish), but the 50-day SMA remains below the 200-day SMA (bearish longer-term backdrop). \nOn the timeline, the stock logged a swing high in March, a swing low in April, and also tagged its 52-week low in April—so this year's rebound is happening after a deep drawdown.\nHCW Biologics shares were up 4.94% at $2.55 at the time of publication on Thursday, according to Benzinga Pro data.\nPhoto Courtesy: Gorodenkoff on Shutterstock.com\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2637352681","isCrawlerRequest":true}